ADHD Trial, Recruiting NCT07364331 Sponsor: China Medical University Hospital Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT07364331
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been officially diagnosed with ADHD according to current diagnostic standards (DSM-5)
  • Your ADHD treatment (whether medication or therapy) has not changed in the 4 weeks before joining the trial
  • Your ADHD symptoms (inattention and/or hyperactivity) score at a certain level on a standard rating scale called the SNAP-IV (confirm with trial site)

Who may not be able to join:

  • Your IQ has been measured as below 80
  • You are allergic to omega-3
  • You have a physical health condition such as a thyroid disorder or cancer
  • You have certain other mental health conditions, including substance use disorder, psychotic disorders, bipolar disorder, or major depressive disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pei-Chen Chang, PhD, China Medical University Hospital

Phone: +88622052121

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
China Medical University Hospital
Registry
ClinicalTrials.gov
Start date
4 September 2021
Est. completion
31 July 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Clinical symptoms-attention and impulsivity symptom severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov